Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1619-7089
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Combination of terbium-161 with somatostatin receptor antagonists—a potential paradigm shift for the treatment of neuroendocrine neoplasms ; day:8 ; month:10 ; year:2021 ; pages:1-14
European journal of nuclear medicine and molecular imaging ; (8.10.2021), 1-14

Creator
Borgna, Francesca
Haller, Stephanie
Rodriguez, Josep M. Monné
Ginj, Mihaela
Grundler, Pascal V.
Zeevaart, Jan Rijn
Köster, Ulli
Schibli, Roger
Van der Meulen, Nicholas P.
Müller, Cristina
Contributor
SpringerLink (Online service)

DOI
10.1007/s00259-021-05564-0
URN
urn:nbn:de:101:1-2021122508145225526248
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Borgna, Francesca
  • Haller, Stephanie
  • Rodriguez, Josep M. Monné
  • Ginj, Mihaela
  • Grundler, Pascal V.
  • Zeevaart, Jan Rijn
  • Köster, Ulli
  • Schibli, Roger
  • Van der Meulen, Nicholas P.
  • Müller, Cristina
  • SpringerLink (Online service)

Other Objects (12)

Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms

Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms

Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin

Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin

Neuroendocrine neoplasms: radiologic-clinical correlation

Neuroendocrine neoplasms: radiologic-clinical correlation

P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms

P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms

Some Considerations on Laryngeal Neuroendocrine Neoplasms

Some Considerations on Laryngeal Neuroendocrine Neoplasms

Imaging presentation of pancreatic neuroendocrine neoplasms

Imaging presentation of pancreatic neuroendocrine neoplasms

Management of Functional Pancreatic Neuroendocrine Neoplasms

Management of Functional Pancreatic Neuroendocrine Neoplasms

New Developments in Gastric Neuroendocrine Neoplasms

New Developments in Gastric Neuroendocrine Neoplasms

New Directions in Imaging Neuroendocrine Neoplasms

New Directions in Imaging Neuroendocrine Neoplasms

Update Regarding Imaging of Neuroendocrine Neoplasms

Update Regarding Imaging of Neuroendocrine Neoplasms

Long-term surgical outcomes of gastric neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasms

Long-term surgical outcomes of gastric neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasms

Mixed neuroendocrine–non-neuroendocrine neoplasms of the gallbladder: a case report

Mixed neuroendocrine–non-neuroendocrine neoplasms of the gallbladder: a case report

Related objects